PubMed=7329817
Michael G. Brattain, Diane E. Brattain, W. David Fine, F. Mahnaz Khaled, Michael E. Marks, Pamela M. Kimball, Laurie A. Arcolano, Bernice H. Danbury;
Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts.
Oncodev. Biol. Med. 2:355-366(1981)

PubMed=6578361; DOI=10.1093/jnci/71.4.663
Michael E. Marks, Bernice H. Danbury, Charles A. Miller 3rd, Michael G. Brattain;
Cell surface proteins and glycoproteins from biologically different human colon carcinoma cell lines.
J. Natl. Cancer Inst. 71:663-671(1983)

PubMed=6437669; DOI=10.1007/BF00048384
Michael G. Brattain, Alan E. Levine, Subhas Chakrabarty, Lynn C. Yeoman, James K.V. Willson, Bing Long;
Heterogeneity of human colon carcinoma.
Cancer Metastasis Rev. 3:177-191(1984)

PubMed=3349466
Isabelle Chantret, Alain Barbat, Elisabeth Dussaulx, Michael G. Brattain, Alain Zweibaum;
Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.
Cancer Res. 48:1936-1942(1988)

PubMed=17363507; DOI=10.1158/1535-7163.MCT-06-0555
Jing Wang, Karen K. Kuropatwinski, Jennie Hauser, Michael R. Rossi, Yun-Fei Zhou, Alexis Conway, Julie L.C. Kan, Neil W. Gibson, James K.V. Willson, John Kenneth Cowell, Michael G. Brattain;
Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.
Mol. Cancer Ther. 6:1143-1150(2007)